QGold Announces $2,000,000 Private Placement Flow-Through Financing
Globenewswire· 2025-12-09 23:00
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Q-Gold Resources Ltd. (TSXV: QGR; OTCQB: QGLDF; Börse Frankfurt: QX9G) (“QGold” or the “Company”) announces today that it intends to complete a best efforts non-brokered private placement financing of up to 5,714,285 common shares of the Company (each, a “Flow-Through Share”) issued on a “flow-through basis” for proceeds of up to approximately $2,000,000 (the “Offering”). ...
Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Globenewswire· 2025-12-09 22:45
– Financing includes leading U.S. biotechnology institutional investors and mutual funds – LOS ANGELES, CA, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a global leader in relapsed/refractory AL Amyloidosis, today announced the closing of its previously announced underwritten registered offering of 19,117,646 shares of its common stock at a price to the public of $5.10 per share, and to certain investors in lieu of common stock, pre-funded warrants ...
Orchid Island Capital Announces December 2025 Monthly Dividend and November 30, 2025 RMBS Portfolio Characteristics
Globenewswire· 2025-12-09 22:29
December 2025 Monthly Dividend of $0.12 Per Share of Common StockRMBS Portfolio Characteristics as of November 30, 2025Next Dividend Announcement Expected January 7, 2026 VERO BEACH, Fla., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Orchid Island Capital, Inc. (the “Company”) (NYSE: ORC) announced today that the Board of Directors of the Company declared a monthly cash dividend for the month of December 2025. The dividend of $0.12 per share will be paid January 29, 2026 to holders of record of the Company’s common st ...
Canadian Banc Corp. Announces Class A Share Split
Globenewswire· 2025-12-09 22:28
Core Viewpoint - Canadian Banc Corp. plans to execute a share split of its Class A shares due to strong performance, with shareholders receiving additional shares [1] Share Split Details - Class A shareholders will receive 10 additional shares for every 100 shares held, effective for those on record by December 16, 2025 [1] - The share split is subject to approval by the Toronto Stock Exchange [1] - The Class A shares will begin trading on an ex-split basis on December 16, 2025, with no fractional shares issued [3] Cash Distributions - Class A shareholders will continue to receive monthly cash distributions targeted at an annualized rate of 15%, based on the volume weighted average market price for the last three trading days of the preceding month [2] - Since inception, cash distributions have totaled $24.60 per share [2] Investment Portfolio - The Company invests in a portfolio of six publicly traded Canadian banks, including Bank of Montreal, Canadian Imperial Bank of Commerce, National Bank of Canada, Royal Bank of Canada, Bank of Nova Scotia, and Toronto-Dominion Bank [4] - The weight of shares in the portfolio is expected to range between 5-20% but may vary [4] - The Company also engages in a selective covered call writing program to generate additional returns [4]
KOIL Energy to Present at Sidoti’s Year-End Virtual Investor Conference December 10-11
Globenewswire· 2025-12-09 22:22
HOUSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Koil Energy Solutions, Inc. (OTCQB: KLNG), a specialist in deepwater energy production and distribution equipment and services, announced Erik Wiik, President and Chief Executive Officer of KOIL Energy, and Kurt Keller, Chief Financial Officer of KOIL Energy, will present and host one-on-one meetings with investors at Sidoti’s Year-End Virtual Investor Conference, taking place on December 10-11, 2025. The presentation will begin at 10:00 am ET on Thursday, December ...
CPI Aerostructures Appoints Robert Mannix as Chief Financial Officer
Globenewswire· 2025-12-09 22:15
Core Insights - CPI Aerostructures, Inc. has appointed Robert Mannix as the new Chief Financial Officer, succeeding Pamela Levesque, who will remain on the Board of Directors [1][5] Company Overview - CPI Aero is a prime contractor to the U.S. Department of Defense and a Tier 1 subcontractor to major aerospace and defense contractors, providing engineering, program management, supply chain management, assembly operations, and MRO services [6] - The company is recognized for its capabilities in aircraft structural assemblies, military advanced tactical pod structures, engine air inlets, and complex welded products, combining large-company capabilities with small-company value and responsiveness [6] Leadership Background - Robert Mannix brings over 30 years of experience in financial operations, including roles in accounting, financial reporting, audit and compliance, treasury, tax, and financial planning [2] - Prior to joining CPI Aero, Mannix held senior positions at West Technology Group and Verint Systems, and began his career at Ernst & Young [3][4]
Dorchester Minerals, L.P. Announces the Retirement of Mr. William Casey McManemin from the Board of Managers; Appointments of Mr. Robert C. Vaughn as Interim Chairman and Mr. Albert G. Nance III to the Board of Managers
Globenewswire· 2025-12-09 22:11
DALLAS, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) announces the retirement of Mr. William Casey McManemin from the Board of Managers of Dorchester Minerals Management GP LLC, the general partner of the Partnership’s general partner (the “Board”), effective December 31, 2025. Mr. McManemin previously led the Partnership as Chief Executive Officer for over 19 years and has been a member and Chairman of the Board since the Partnership’s inception in 2003. As ...
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease
Globenewswire· 2025-12-09 22:07
SEATTLE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced Dr. Harlan Robins, Chief Scientific Officer and Co-Founder and Susan Bobulsky, Chief Commercial Officer, MRD will be participating in a Jefferies fireside chat to discuss Minimal Residual Disease (MRD) in Hematology/Oncology with deep dive ...
Medicenna Therapeutics to Host a Live Webinar with Q&A to Discuss Updated MDNA11 Clinical Data
Globenewswire· 2025-12-09 22:04
TORONTO and HOUSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines for the treatment of cancer as well as autoimmune and inflammatory diseases is pleased to announce that it will host a live webinar on December 10, 2025 at 08:30 AM Eastern Time. As previously announced, Medicenna will present updated clinical data from the ABILITY-1 Phase 1/2 Study, evalu ...
Constellation Software Inc. Announces Appointment of Mark Miller to its Board of Directors
Globenewswire· 2025-12-09 22:04
TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX:CSU) (“Constellation”) announced today the appointment of Mark Miller to Constellation’s Board of Directors. Mr. Miller is the President of Constellation, and Executive Chairman of the Volaris Group. Mr. Miller has worked with Constellation, Volaris Group and its subsidiaries for more than 30 years. Mr. Miller co-founded Trapeze Group in 1988, which was the first company acquired by Constellation in 1995. About Constellation Softwar ...